Kevin Petrecca and Frédéric Leblond

An infallible hand-held probe to aid cancer surgery

June 28, 2017
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cells
Lire la suite
Scientific core facilities

Dare to discover thanks to the CRCHUM’s scientific core facilities

June 20, 2017
The University of Montreal Hospital Research Centre (CRCHUM) is launching a video brief that seeks to familiarize researchers in Canada working in the biomedical sciences with its cutting-edge services and facilities.
Lire la suite

Charles M. Rice becomes honorary CRCHUM researcher

June 16, 2017
A Rockefeller University professor and the director of New York City’s Center for the Study of Hepatitis C, Charles M. Rice, along with his team, have contributed to many scientific breakthroughs in virology, including the description of the mechanisms of hepatitis C virus (HCV) infection in humans and the identification of therapeutic targets.
Lire la suite
transplantation

Kidney graft success — does age and sex matter?

June 8, 2017
New study hints at the role of estrogen in graft success and suggests that patients could benefit from personalized immunosuppression strategies
Lire la suite
Charles Rice

Unraveling Nature's Intrinsic and Innate Antiviral Defenses

June 5, 2017
For the CRCHUM conference taking place on June 16, 2017, Charles M. Rice, Professor of virology at The Rockefeller University, will highlight a new finding in stem cells that has changed his thinking about the evolution and function of cell type-specific antiviral immunity.
Lire la suite
Lora Hooper

The gut microbiome: a master regulator of metabolism

June 2, 2017
For the CRCHUM conference taking place on June 9, 2017, Lora Hooper, Professor of immunology at the University of Texas Southwestern Medical Center, will speak about how resident intestinal bacteria regulate our metabolism.
Lire la suite
Minocycline

Common acne medication offers new treatment for multiple sclerosis

May 31, 2017
A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), with the University of Montreal Hospital (CHUM) as one of the investigative sites, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
Lire la suite
Patrick Laplante and Jean-François Cailhier

Healing wounds with cell therapy

May 29, 2017
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds. This approach could prove to be beneficial in healing challenging wounds in diabetics and major-burn victims.
Lire la suite
Hertzel C. Gerstein

Is “Real World” Evidence a Reliable Way to Identify Effective Therapies?

May 26, 2017
For the CRCHUM conference taking place on June 2, 2017, Hertzel C. Gerstein, Professor of Medicine at the McMaster University, will speak about different sources of data for assessing therapeutic effectiveness, using the example of diabetes.
Lire la suite
Caesarean

Improving health care for mother and child, doing fewer caesareans and… saving money!

May 23, 2017
A training program to improve obstetrical management reduced the number of medically unjustified caesareans and generated significant savings for the healthcare system in Quebec (Canada), in addition to improving the quality of healthcare provided to mothers and babies.
Lire la suite

Pages